Sicilian Welfare-Covered Medical Cannabis Is Now a Thing

In the recent years, Italy has been attempting to craft a legal cannabis consumption and market program, without success. As those in the industry know, the current situation there is uncertain.
Medical Team
Written by Medical Team, Leafreport's Clinician Team
Last Updated
Cannabis legalization

Especially in light of the legacy of the former Minister of Internal Affairs, Northern League’s leader, Matteo Salvini, who, just three months ago, celebrated a Senate vote against the legalization of cannabis, in an attempt to even tackle the status quo in regards to the Italian CBD market, based off EU-certified non-psychoactive cultivars.

However, in the face of so much political adversity, there are some good news for those who in Italy consume cannabis for medical reasons. Thanks to a decree signed by the Councilman for Health, Ruggero Razza, the Sicilian Region decided to approve the budget to cover for the costs incurred by patients. The cannabis products (Including Bedrocan’s high-CBD cuitivars Bediol and Bedrolite) that the country imports for its patients are now free of charge for those suffering from chronic and neuropathic pain and spasticity from multiple sclerosis. The document defined in detail all the rules for the prescription, preparation, dispensing and reimbursement of galenic or even industrial cannabis-based preparations for medical use, like Epidiolex or Sativex.

The prescription of the drug is only permitted on the basis of a therapeutic plan with a maximum duration of six months, renewable if necessary. The only physicians allowed to prescribe the drug are those employed by regional public health agencies, or specialists in anesthesia and resuscitation, neurology and pain therapy centers. Cannabis may be prescribed for oral use (for the preparation of decoctions), for inhalation use (by means of specific vaporizers and related cartridges) and by means of oil for oral use. Training courses for doctors are already being organized and will be carried out in all the Sicilian provinces by the Italian national medical association (the Ordine dei Medici).

Gaetano D’Amico, leader of the Italian cannabis medicine patients’ committee, defined it “a big step forward”, although not fully satisfactory, given many diseases have remained outside the scope of this reform. Now the challenge is cultivation in Sicily. According to D’Amico, there are many interested realities, and also the Sicilian Agricultural Development Agency had given availability of its fields for cultivation on site for therapeutic purposes. Ruggero Razza’s policy choice on the matter of cannabinoid-based therapy represents, for the region of Sicily, the culmination of a years-long effort in favor of medical cannabis users’ rights.

 

ENJOY READING? SHARE THIS ARTICLE
Medical Team
Medical Team
Leafreport's Clinician Team
The clinicians in our team bring their experience from across the spectrum of medical specialties, as well as their perspective from years of clinical practice, research, and patient advocacy. Medical Review, provided by members of Leafreport's team, ensures that our content is accurate, current, and patient-focused.

Read More

Leafreport picks for best cbd oil
FOLLOW US
Important Disclaimer
All contents of the LeafReport Site, such as text, graphics, images, and other material contained on the LeafReport Site are for informational purposes only. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on the LeafReport Site!